Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non–Small-Cell Lung Cancer

Published:2015-09 Issue:5 Volume:16 Page:385-390
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Kitazono Satoru,Fujiwara Yutaka^ORCID,Tsuta Koji,Utsumi Hirofumi,Kanda Shintaro,Horinouchi Hidehito,Nokihara Hiroshi,Yamamoto Noboru,Sasada Shinji,Watanabe Shun-ichi,Asamura Hisao,Tamura Tomohide,Ohe Yuichiro

Funder

National Cancer Center Research and Development

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference26 articles.

1. Gefitinib or chemotherapy for non–small-cell lung cancer with mutated EGFR;Maemondo;N Engl J Med,2010

2. Gefitinib versus cisplatin plus docetaxel in patients with non–small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial;Mitsudomi;Lancet Oncol,2010

3. Effect of crizotinib on overall survival in patients with advanced non–small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis;Shaw;Lancet Oncol,2011

4. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non–small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study;Zhou;Lancet Oncol,2011

5. ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development;Scagliotti;Eur J Cancer,2012

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in pathological diagnoses between bronchoscopic tissue and resected specimens of non-small cell lung cancer: A retrospective single center study;2024-08-10

2. The efficacy outcomes in non-small cell lung cancer patients treated with PD axis inhibitor agents - a population-based study of the Vojvodina region;Pathology and Oncology Research;2024-07-12

3. Immunohistochemistry of Lung Cancer Biomarkers;Advances in Anatomic Pathology;2024-04-26

4. Prediction of Tumor PD-L1 Expression in Resectable Non-Small Cell Lung Cancer by Machine Learning Models Based on Clinical and Radiological Features: Performance Comparison With Preoperative Biopsy;Clinical Lung Cancer;2024-01

5. PD-L1 assessment in lung cancer biopsies—pitfalls and limitations;The International Journal of Biological Markers;2023-12-18